Skip to main content
. 2018 Nov 20;77(1):1546069. doi: 10.1080/22423982.2018.1546069

Table 3.

Oncological treatment characteristics for patients with CRC in Greenland 2004–2012.

  No Percentage of subgroup
Adjuvant treatment (n = 50)    
UICC II (high risk) 11 18% of all st II
UICC III 33 79% of all st III
After surgery for metastatic disease 8  
Palliative treatment (n = 44)    
UICC IV 25 61% of all st IV
Recurrence 19 46% of all with recurrence